1-13 of 13
Khalid Amin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PD17-12: Primary efficacy and safety results from the AMALEE trial evaluating 600 mg vs 400 mg starting doses of first-line ribociclib in patients with HR+/HER2− advanced breast cancer

Free
Fatima Cardoso, William Jacot, Sherko Küemmel, Sudeep Gupta, Rama Balaraman, Liudmila Lebedeva, Yan Ji, Aparna Lakshmanan, Khalid Amin, Zheng Li, Joseph Sparano
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): PD17-12.
https://doi.org/10.1158/1538-7445.SABCS22-PD17-12
Published: 01 March 2023
View articletitled, Abstract PD17-12: Primary efficacy and safety results from the AMALEE trial evaluating 600 mg vs 400 mg starting doses of first-line ribociclib in patients with HR+/HER2− advanced breast cancer
Journal Articles

Sleeping Beauty Insertional Mutagenesis in Mice Identifies Drivers of Steatosis-Associated Hepatic Tumors

Available to Purchase
Barbara R. Tschida, Nuri A. Temiz, Timothy P. Kuka, Lindsey A. Lee, Jesse D. Riordan, Carlos A. Tierrablanca, Robert Hullsiek, Sandra Wagner, Wendy A. Hudson, Michael A. Linden, Khalid Amin, Pauline J. Beckmann, Rachel A. Heuer, Aaron L. Sarver, Ju Dong Yang, Lewis R. Roberts, Joseph H. Nadeau, Adam J. Dupuy, Vincent W. Keng, David A. Largaespada
Journal: Cancer Research
Cancer Res (2017) 77 (23): 6576–6588.
https://doi.org/10.1158/0008-5472.CAN-17-2281
Published: 30 November 2017
View articletitled, Sleeping Beauty Insertional Mutagenesis in Mice Identifies Drivers of Steatosis-Associated Hepatic Tumors
Open the PDF for Sleeping Beauty Insertional Mutagenesis in Mice Identifies Drivers of Steatosis-Associated Hepatic Tumors in another window
Includes: Supplementary data
Journal Articles

Abstract CT104: A first-in-human phase I dose escalation study of BET inhibitor GSK2820151 in patients with advanced or recurrent solid tumors cancers

Free
Shirish Gadgeel, Vicki Keedy, Simon Taylor, Khalid Amin, Thierry Horner, Yuehui Wu, Rab Prinjha, Arindam Dhar, Brandon Kremer
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): CT104.
https://doi.org/10.1158/1538-7445.AM2017-CT104
Published: 01 July 2017
View articletitled, Abstract CT104: A first-in-human phase I dose escalation study of BET inhibitor GSK2820151 in patients with advanced or recurrent solid tumors cancers
Journal Articles

Abstract #517: The metal-responsive transcription factor-1   is highly expressed in human tumors

Free
Yihui Shi, Khalid Amin, Barbara Sato, Guita Lalehzadeh, Theresamai Le, Steven Samuelsson, Zishan Haroon, Brian Murphy
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 517.
Published: 01 May 2009
View articletitled, Abstract #517: The metal-responsive transcription factor-1   is highly expressed in human tumors
Journal Articles

SR13654: An orally active anticancer agent potently inhibits nuclear survivin expression and suppresses tumor growth in animal models

Free
Dawn Yean, Wan-ru Chao, Khalid Amin, Ling Jong
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 4949.
Published: 01 May 2007
View articletitled, SR13654: An orally active anticancer agent potently inhibits nuclear survivin expression and suppresses tumor growth in animal models
Journal Articles

SR16388 inhibits STAT3 activation and angiogenesis in lung cancer model

Free
Peter Hobbs, Wan-Ru Chao, Khalid Amin, Dawn Yean, Theresamai Le, Mary Tanga, Masato Tanabe
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 4621.
Published: 01 May 2007
View articletitled, SR16388 inhibits STAT3 activation and angiogenesis in lung cancer model
Journal Articles

Comparison between exogenous and endogenous hypoxia markers in human cancer: Pimonidazole and erythropoietin

Free
James A. Raleigh, Murat O. Arcasoy, Khalid Amin, Ruth A. Lininger, Mahesh A. Varia
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 852–853.
Published: 15 April 2006
View articletitled, Comparison between exogenous and endogenous hypoxia markers in human cancer: Pimonidazole and erythropoietin
Journal Articles

SR16388 inhibits non-small cell lung tumor growth and angiogenesis

Free
Peter D. Hobbs, Wan-Ru Chao, Khalid Amin, Carol Green, Theresamai Le, Toufan Parman, Barbara Sato, Robert Swezey, Mary Tanga, Dawn Yean
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 898.
Published: 15 April 2006
View articletitled, SR16388 inhibits non-small cell lung tumor growth and angiogenesis
Journal Articles

SR13654, Targeting survivin, a critical anti-apoptosis protein, for new anticancer intervention.

Free
Wan-Ru Chao, Khalid Amin, Dawn Yean, Ling Jong
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1333.
Published: 15 April 2006
View articletitled, SR13654, Targeting survivin, a critical anti-apoptosis protein, for new anticancer intervention.
Journal Articles

SR13668, an orally effective inhibitor of phospho-Akt: Pharmacokinetics, tissue distribution and safety profile in mice and rats

Free
Ling Jong, Wan-Ru Chao, Khalid Amin, Robert Swezey, Carol Green
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 986–987.
Published: 01 May 2005
View articletitled, SR13668, an orally effective inhibitor of phospho-Akt: Pharmacokinetics, tissue distribution and safety profile in mice and rats
Journal Articles

SR13668: An orally active inhibitor of phospho-Akt potently suppresses tumor growth and synergizes with chemotherapeutics both in vitro and in vivo

Free
Ling Jong, Wan-Ru Chao, Khalid Amin, Dawn Yean
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 401.
Published: 01 May 2005
View articletitled, SR13668: An orally active inhibitor of phospho-Akt potently suppresses tumor growth and synergizes with chemotherapeutics both in vitro and in vivo
Journal Articles

SR16388: A novel angiogenesis inhibitor induces apoptosis, G1 cell cycle arrest, and potently suppresses tumor growth

Free
Peter D. Hobbs, Wan-Ru Chao, Khalid Amin, Richard Peters, Masato Tanabe
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 707.
Published: 01 May 2005
View articletitled, SR16388: A novel angiogenesis inhibitor induces apoptosis, G1 cell cycle arrest, and potently suppresses tumor growth
Journal Articles

SR13668: A novel indole derived inhibitor of phospho-Akt potently suppresses tumor growth in various murine xenograft models.

Free
Ling Jong, Wan-Ru Chao, Khalid Amin, Keith Laderoute, Juan Orduna, Barbara Sato, Glenn Rice
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 849–850.
Published: 01 April 2004
View articletitled, SR13668: A novel indole derived inhibitor of phospho-Akt potently suppresses tumor growth in various murine xenograft models.